Wall Street on Friday ended a listless day with marginal losses, with the session echoing the overall movement seen this week. The blue-chip Dow Jones Industrial Average fell -0.17% to close at 49,359 ...

A new study describes an alternative way of using the body’s own immune cells to treat cancer.

Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

We recently published 10 Stocks Jim Cramer Talked About . Moderna Inc. (NASDAQ:MRNA) is one of the stocks on Jim Cramer ...

Arbutus (ABUS) stock sinks as the European Patent Office revokes a patent that was subject to a legal dispute between the ...

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...

The NIH is a great institution. For the health and welfare of the nation — and here in Utah — it should be protected ...

An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...